After biotech implosions, ex-Millennium chief Deborah Dunsire is taking the helm at Lundbeck
Deborah Dunsire is moving to Denmark.
After bouncing around the high-risk biotech world in Boston/Cambridge for the past few years, ex-Millennium chief Dunsire is now taking the top seat at Denmark’s Lundbeck, left vacant after Kåre Schultz jumped to Teva.
A high-profile exec in the US, Dunsire left Millennium as Takeda absorbed and restructured the company, making it a central part of their US hub. She later took the helm at Forum Pharmaceuticals, leaving not long after the company was hit by a clinical hold on Alzheimer’s and a failed clinical program in schizophrenia.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.